![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LabCorp Introduces Epi proColon Test
LabCorp Introduces Epi proColon Test
Laboratory Corporation of America has launched its Epi proColon test for colorectal cancer, under a joint marketing agreement with Polymedco.
Epi proColon was developed by Epigenomics AG and is the first DNA-based test with this indication, according to the company.
The test, approved last month, pinpoints Epigenomics proprietary Septin9 DNA biomarker in cell-free DNA. The new addition expands the company’s existing portfolio of colorectal cancer offerings. — Anisa Jibrell
Upcoming Events
-
21Oct